151 - 160 out of 189Page size: 10
  1. 2018

  2. Commentary: Establishing zebrafish as a model to study the anxiolytic effects of scopolamine

    de Abreu, M. S., Friend, A. J., Amstislavskaya, T. G. & Kalueff, A. V., 3 Apr 2018, In: Frontiers in Pharmacology. 9, APR, 4 p., 293.

    Research output: Contribution to journal › Comment/debate › peer-review

  3. Modeling consequences of prolonged strong unpredictable stress in zebrafish: Complex effects on behavior and physiology

    Song, C., Liu, B. P., Zhang, Y. P., Peng, Z., Wang, J. J., Collier, A. D., Echevarria, D. J., Savelieva, K. V., Lawrence, R. F., Rex, C. S., Meshalkina, D. A. & Kalueff, A. V., 2 Feb 2018, In: Progress in Neuro-Psychopharmacology and Biological Psychiatry. 81, p. 384-394 11 p.

    Research output: Contribution to journal › Article › peer-review

  4. The developing utility of zebrafish models of neurological and neuropsychiatric disorders: A critical review

    Fontana, B. D., Mezzomo, N. J., Kalueff, A. V. & Rosemberg, D. B., 1 Jan 2018, In: Experimental Neurology. 299, p. 157-171 15 p.

    Research output: Contribution to journal › Review article › peer-review

  5. The effects of auditory enrichment on zebrafish behavior and physiology

    Barcellos, H. H. A., Koakoski, G., Chaulet, F., Kirsten, K. S., Kreutz, L. C., Kalueff, A. V. & Barcellos, L. J. G., 1 Jan 2018, In: PeerJ. 2018, 7, e5162.

    Research output: Contribution to journal › Article › peer-review

  6. Zebrafish models of autism spectrum disorder

    Meshalkina, D. A., N. Kizlyk, M., V. Kysil, E., Collier, A. D., Echevarria, D. J., Abreu, M. S., Barcellos, L. J. G., Song, C., Warnick, J. E., Kyzar, E. J. & Kalueff, A. V., 1 Jan 2018, In: Experimental Neurology. 299, p. 207-216 10 p.

    Research output: Contribution to journal › Review article › peer-review

  7. Interplay between the key proteins of serotonin system in SSRI antidepressants efficacy

    Kulikov, A. V., Gainetdinov, R. R., Ponimaskin, E., Kalueff, A. V., Naumenko, V. S. & Popova, N. K., 2018, In: Expert opinion on therapeutic targets. 22, 4, p. 319-330 12 p.

    Research output: Contribution to journal › Review article › peer-review

  8. 2017

  9. Understanding taurine CNS activity using alternative zebrafish models

    Mezzomo, N. J., Fontana, B. D., Kalueff, A. V., Barcellos, L. J. G. & Rosemberg, D. B., 1 Dec 2017, In: Neuroscience and Biobehavioral Reviews. 83, p. 525-539 15 p.

    Research output: Contribution to journal › Review article › peer-review

  10. Psychedelic Drugs in Biomedicine

    Kyzar, E. J., Nichols, C. D., Gainetdinov, R. R., Nichols, D. E. & Kalueff, A. V., 1 Nov 2017, In: Trends in Pharmacological Sciences. 38, 11, p. 992-1005 14 p.

    Research output: Contribution to journal › Review article › peer-review

  11. Adult zebrafish in CNS disease modeling: A tank that's half-full, not half-empty, and still filling

    Meshalkina, D. A., Kysil, E. V., Warnick, J. E., Demin, K. A. & Kalueff, A. V., 6 Oct 2017, In: Lab Animal. 46, 10, p. 378-387 10 p.

    Research output: Contribution to journal › Review article › peer-review

  12. Animal inflammation-based models of depression and their application to drug discovery

    Ma, L., Demin, K. A., Kolesnikova, T. O., Kharsko, S. L., Zhu, X., Yuan, X., Song, C., Meshalkina, D. A., Leonard, B. E., Tian, L. & Kalueff, A. V., 3 Oct 2017, In: Expert Opinion on Drug Discovery. 12, 10, p. 995-1009 15 p.

    Research output: Contribution to journal › Review article › peer-review

Previous 1...12 13 14 15 16 17 18 19 Next

ID: 441590